A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

Abstract Background A previous phase 2 study demonstrated the immunogenicity of a single dose of meningococcal A, C, W, Y-tetanus toxoid conjugate (MenACWY-TT) or polysaccharide (MenACWY-PS) vaccine for up to 5 years in individuals aged 11–55 years. This follow-up study evaluated long-term antibody...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Charissa Fay Corazon Borja-Tabora, Paula Peyrani, Chris Webber, Marie Van der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Veronique Bianco, Emmanuel Aris, Mark Cutler, Ping Li, John L. Perez
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2020-06-01
Schriftenreihe:	BMC Infectious Diseases
Schlagworte:	Antibody Immunogenicity MenACWY-TT Meningococcal Persistence Booster
Online-Zugang:	http://link.springer.com/article/10.1186/s12879-020-05104-5
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!